Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SGN-MesoC2 |
Synonyms | |
Therapy Description |
SGN-MesoC2 is an antibody-drug conjugate (ADC) comprising an anti-MSLN antibody linked to a camptothecin-based topoisomerase I inhibitor, which potentially induces cytotoxicity in MSLN-expressing tumor cells and antitumor activity (Cancer Res (2025) 85 (8_Supplement_1): 324). |